BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34034913)

  • 1. Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
    Jia M; Hu BF; Xu XJ; Zhang JY; Li SS; Tang YM
    Curr Probl Cancer; 2021 Dec; 45(6):100758. PubMed ID: 34034913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognostic significance of TCF3-PBX1 fusion gene in Chinese children with acute lymphoblastic leukemia by using a modified ALL-BFM-95 protocol.
    Pang L; Liang Y; Pan J; Wang JR; Chai YH; Zhao WL
    Pediatr Hematol Oncol; 2015 Apr; 32(3):173-81. PubMed ID: 25551271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Results of the Risk-Stratified Treatment of TCF3-PBX1-Positive Pediatric Acute Lymphoblastic Leukemia in China.
    Wang Y; Xue YJ; Lu AD; Jia YP; Zuo YX; Zhang LP
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e137-e144. PubMed ID: 33221150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong.
    Lin A; Cheng FWT; Chiang AKS; Luk CW; Li RCH; Ling ASC; Cheuk DKL; Chang KO; Ku D; Lee V; Ha SY; Li CK
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27346. PubMed ID: 30051646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
    Felice MS; Gallego MS; Alonso CN; Alfaro EM; Guitter MR; Bernasconi AR; Rubio PL; Zubizarreta PA; Rossi JG
    Leuk Lymphoma; 2011 Jul; 52(7):1215-21. PubMed ID: 21534874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
    Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
    Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric acute lymphoblastic leukemia with t(1;19)/TCF3-PBX1 in Taiwan.
    Yen HJ; Chen SH; Chang TY; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Chang TK; Peng CT; Lin MT; Jaing TH; Liu HC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Hung GY; Wu KH; Yeh TC; Wang SC; Chen RL; Chang HH; Yang YL; Chen SH; Cheng SN; Chang YH; Chen BW; Hsieh YL; Huang FL; Ho WL; Wang JL; Chang CY; Chao YH; Lin PC; Chen YC; Liao YM; Lin TH; Shih LY; Liang DC
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of TCF3 rearrangement on CNS relapse in egyptian pediatric acute lymphoblastic leukemia.
    ElGendi HM; Abdelmaksoud AA; Eissa DG; Abusikkien SA
    Pediatr Hematol Oncol; 2014 Oct; 31(7):638-46. PubMed ID: 25116187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in Japan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children's Cancer and Leukemia Study Group (CCLSG).
    Asai D; Imamura T; Yamashita Y; Suenobu S; Moriya-Saito A; Hasegawa D; Deguchi T; Hashii Y; Endo M; Hatakeyama N; Kawasaki H; Hori H; Horibe K; Yumura-Yagi K; Hara J; Watanabe A; Kikuta A; Oda M; Sato A;
    Cancer Med; 2014 Jun; 3(3):623-31. PubMed ID: 24578304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Significance of Minimal Residual Disease in Pediatric Patients with
    Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1303-1308. PubMed ID: 37846676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.
    Gao C; Zhao XX; Li WJ; Cui L; Zhao W; Liu SG; Yue ZX; Jiao Y; Wu MY; Li ZG
    Am J Hematol; 2012 Nov; 87(11):1022-7. PubMed ID: 22911440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical and laboratory study of TCF3-PBX1 positive adult acute lymphoblastic leukemia.].
    Zheng JF; Qiu HY; Pan JL; Cen JN; Wu YF; Zhang J; Wu DP; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):16-20. PubMed ID: 20302770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
    Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
    Kager L; Lion T; Attarbaschi A; Koenig M; Strehl S; Haas OA; Dworzak MN; Schrappe M; Gadner H; Mann G;
    Haematologica; 2007 Nov; 92(11):1561-4. PubMed ID: 18024406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
    Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
    Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic efficacy of pediatric ALL patients with MLL gene rearrangement treated with CCLG-ALL2008 protocol.
    Sun YN; Hu YX; Gao L; Xiao PF; Lu J; Wu SY; Wang M; Shao XJ; Zhou CY; Ling J; Li JQ; Pan J; Gao J; Hu SY
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6020-6029. PubMed ID: 30280786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the efficacy of two successive protocols on pediatric acute lymphoblastic leukemia with E2A-PBX1 fusion gene].
    Mei YY; Gao C; Cui L; Zhao XX; Zhao W; Li WJ; Wang KL; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Li ZG
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):467-71. PubMed ID: 24120066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Correlation of Minimal Residual Disease with Prognosis in TCF3-PBX1
    Zhang L; Zou Y; Ai XF; Cao Z; Chen YM; Guo Y; Yang WY; Chen XJ; Wang SC; Liu XM; Ruan M; Liu TF; Liu F; Qi BQ; Chang LX; An WB; Ren YY; Li QH; Zhu XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1831-1836. PubMed ID: 33283706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing.
    Salim M; Heldt F; Thomay K; Lentes J; Behrens YL; Kaune B; Möricke A; Cario G; Schieck M; Hofmann W; Davenport C; Steinemann D; Schrappe M; Schlegelberger B; Göhring G
    Genes Chromosomes Cancer; 2022 Jan; 61(1):22-26. PubMed ID: 34460133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
    Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
    Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.